Dexcel Pharma Technologies Ltd.   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Akiva Israel (1968)
Status: No NME R&D (1968)

Organization Overview

First Clinical Trial
2008
NCT00425451
First Marketed Drug
1998
chlorhexidine (hibitane)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

DEXCEL LTD | DEXCEL PHARMA